Table:
begin	end	state
1	20	cytoplasmic
21	41	transmembrane
42	47	non-cytoplasmic
48	70	transmembrane
71	91	cytoplasmic
92	114	transmembrane
115	125	non-cytoplasmic
126	144	transmembrane
145	154	cytoplasmic
155	176	transmembrane
177	195	non-cytoplasmic
196	215	transmembrane
216	235	cytoplasmic
236	255	transmembrane
256	284	non-cytoplasmic
285	312	transmembrane
313	332	cytoplasmic
333	353	transmembrane
354	358	non-cytoplasmic
359	383	transmembrane
384	391	cytoplasmic
392	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	449	cytoplasmic

Input:
>Pf6N2E2_2179 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_2179
MSIEAFGYKQELKRGLSLTDLVVYGMIFMIPIAPFGVYGYVNAEAPGMVPLAYIIGMVAM
LFTALSYGSMARAFPVAGSVYSYAQRGLNPHVGFIAGWLMLLDYLLIPPLLYVYASMALN
HLYPDIPKVGFILAFLVSATFVNLRGITFTARMNIIFLLAQLVVLGIFLFYAWNALHGGA
GNGQLTLAPLYSPEHFNFALLMQAVSIAVLSFLGFDAISTLAEEIKGDPGRSVGKAALVT
LLVMGAIFVVQTWIATDLAAGMGFKSADTAFYEIAELAAGSWLATLTAVATALAWGVAVA
ITSQAAVSRLLFGMARDGQLPKVLAKVHPTHNTPYLSIYLVAVLSLLICYLFIDAVDTLT
SLVNFGALSGFMLLHITVINHYWRRQQSGQLIRHLICPLVGFVIVAAIMYNMGVAAQKLG
LIWIAAGVIYLCVLNKFGNPTAVPDPAGQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server